Award
NIH Reporter #1R01CA300666-01A1
Advancing early colorectal cancer diagnosis and risk stratification using DNA methylation markers
Recipient
UNIVERSITY OF CHICAGO
Award Amount
$692,063.00
Ceiling
$692,063.00
Awarded
August 19, 2026
Identifier
1R01CA300666-01A1
Award for developing a blood-based epigenetic test for early colorectal cancer detection and risk stratification using DNA methylation markers, managed by the National Cancer Institute.
Description
The project focuses on developing a blood-based epigenetic test for early detection and risk stratification of colorectal cancer using DNA methylation markers. It involves innovative techniques such as LABS (Linear Amplification-based Bisulfite Sequencing) and aims to improve screening compliance and prognostication in colorectal cancer. The project duration is from September 1, 2026, to August 31, 2031.